Q1 2024 · 13F-HR
JOHNSON & JOHNSON (JNJ)holdings as filed
Filed 2024-05-10 · accession 0000904454-24-000285
$4.41B
Reported value
22
Positions
2024-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 49177J102 | KVUE | Kenvue Inc. | $3.91B | 88.7% | 182,329,550 | Common | SHARED |
| 36118A100 | — | Fusion Pharmaceuticals Inc. | $78.3M | 1.77% | 3,670,516 | Common | SHARED |
| 126638105 | CVRX | CVRx, Inc. | $74.7M | 1.69% | 4,103,430 | Common | SHARED |
| 74366E102 | PTGX | Protagonist Therapeutics Inc. | $70.9M | 1.61% | 2,449,183 | Common | SHARED |
| 82489T104 | SWAVUSD | Shockwave Medical, Inc. | $54.3M | 1.23% | 166,812 | Common | SHARED |
| 52490G102 | LEGN | Legend Biotech Corporation | $45.7M | 1.04% | 814,586 | Common | SHARED |
| G59665102 | MGTX | MeiraGTx Holdings plc | $40.3M | 0.91% | 6,641,064 | Common | SHARED |
| 63009J107 | NBTX | Nanobiotix S.A. | $36.6M | 0.83% | 5,623,816 | Common | SHARED |
| 640979100 | NMRA | Neumora Therapeutics, Inc. | $25.4M | 0.58% | 1,849,445 | Common | SHARED |
| 31189P102 | FATE | Fate Therapeutics, Inc. | $24.8M | 0.56% | 3,379,064 | Common | SHARED |
| 74276L105 | PRCT | Procept BioRobotics Corporation | $17.7M | 0.40% | 357,939 | Common | SHARED |
| 98401F105 | XNCR | Xencor, Inc. | $16.6M | 0.38% | 748,062 | Common | SHARED |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals, Inc. | $7.1M | 0.16% | 247,598 | Common | SHARED |
| 929033108 | — | Vor Biopharma, Inc. | $2.5M | 0.06% | 1,074,658 | Common | SHARED |
| M70700105 | NNOX | Nano-X Imaging Ltd. | $1.6M | 0.04% | 158,852 | Common | SHARED |
| 01438T106 | ALDX | Aldeyra Therapeutics, Inc. | $979,918 | 0.02% | 299,669 | Common | SHARED |
| 09090D103 | — | BiomX Inc. | $865,440 | 0.02% | 1,923,201 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio, Inc. | $856,509 | 0.02% | 364,472 | Common | SHARED |
| 34385P108 | LAB | Standard BioTools Inc | $845,431 | 0.02% | 311,967 | Common | SHARED |
| 185063104 | CLSDUSD | Clearside Biomedical, Inc. | $259,532 | 0.01% | 169,629 | Common | SHARED |
| 89237H209 | — | Tracon Pharmaceuticals, Inc. | $36,104 | 0.00% | 84,003 | Common | SHARED |
| 81727U105 | SENS1GBP | Senseonics Holdings, Inc. | $29,009 | 0.00% | 54,621 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.